Trxade Group, Inc. (MEDS)
Market Cap | 38.60M |
Revenue (ttm) | 17.12M |
Net Income (ttm) | -2.54M |
Shares Out | 7.71M |
EPS (ttm) | -0.33 |
PE Ratio | n/a |
Forward PE | 21.83 |
Dividend | n/a |
Dividend Yield | n/a |
Trading Day | April 16 |
Last Price | $4.77 |
Previous Close | $4.76 |
Change ($) | 0.01 |
Change (%) | 0.21% |
Day's Open | 4.90 |
Day's Range | 4.60 - 4.90 |
Day's Volume | 54,733 |
52-Week Range | 4.02 - 8.25 |
TAMPA, FL / ACCESSWIRE / April 12, 2021 / Trxade Group, Inc. (NASDAQ:MEDS) , a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the presc...
CEO Suren Ajjarapu to Present Wednesday, April 21st, 2021 TAMPA, FL / ACCESSWIRE / April 9, 2021 / Trxade Group, Inc. (NASDAQ:MEDS), a health services IT company focused on digitalizing the retail pharm...
Continues Nationwide Expansion of Breakthrough Digital Healthcare Services IT Platform
TAMPA, FL / ACCESSWIRE / March 15, 2021 / Trxade Group, Inc. (NASDAQ:MEDS) , is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the pr...
TAMPA, FL / ACCESSWIRE / March 5, 2021 / Trxade Group, Inc. (NASDAQ:MEDS), a technology-enabled health services platform company focused on digitalizing the retail pharmacy experience, today announced t...
TAMPA, FL, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Trxade Group, Inc. ( MEDS ) an integrated drug procurement, delivery and healthcare platform, today announced that management will present at the Diamond Equ...
Trxade Group Inc. (NASDAQ: MEDS) shares jumped on Tuesday after the company announced that it entered into a definitive agreement with Amazon.com Inc.
Shares of Trxade Group Inc. soared 56% in active trading to pace all of the premarket's gainers Tuesday, after the online platform for pharmaceutical purchases announced a market program agreement with ...
About MEDS
Trxade Group, Inc., together with its subsidiaries, operates a business-to-business (B2B) web-based marketplace focused on the pharmaceutical industry in the United States. It operates through Trxade, Inc.; Community Specialty Pharmacy, LLC; Integra Pharma, LLC; and Other segments. The company operates a web-based market platform that enables commerce among healthcare buyers and sellers of pharmaceuticals, accessories, and services. Its principal products and services include Trxade.com, a web-based pharmaceutical marketplace; InventoryRx.com, ... [Read more...]
Industry Pharmaceutical Retailers | IPO Date Feb 13, 2020 |
Stock Exchange NASDAQ | Ticker Symbol MEDS |
Financial Performance
In 2020, Trxade Group's revenue was $17.12 million, an increase of 130.26% compared to the previous year's $7.44 million. Losses were -$2.54 million, 791.6% more than in 2019.
Analyst Forecasts
According to 3 analysts, the average rating for Trxade Group stock is "Buy." The 12-month stock price forecast is 11.50, which is an increase of 141.09% from the latest price.